At inSeption Group, we don’t just crunch numbers—we transform data into confident action. Your trial’s success hinges on how well data is planned, analyzed, and delivered, and we make sure every finding moves your program forward.

Enables secure real-time document review, co-authoring, and redaction in order to shorten the document review process by up to 65%.

Developing a therapy for a rare or ultra-rare disease is life-changing work with unique challenges. Examine how natural history data is being used to inform the clinical development process.

Ergomed’s Risk-Based Clinical Monitoring and Source Data Verification Approach for Data Integrity

Ergomed ensures the highest data integrity and patient safety standards through our risk-based clinical monitoring and Source Data Verification (SDV) practices. SDV is a critical process in clinical trials that ensures the data collected are accurate, complete, and verifiable against the source documents. We compare data entered into case report forms or electronic data capture systems with the source data to confirm their accuracy and reliability.

What can 22,000 people with an AI-mindset accomplish?

Speed without shortcuts

AI in clinical development at Parexel enables our teams to surface predictive insights at every stage, reducing protocol risk, study delays, and costly trial amendments.

Parexel's approach to AI in clinical development is built on the Precision Pathway, a strategic operating model that embeds AI across the full trial lifecycle. AI empowers our teams at critical decision points to:

1. Simplify complex tasks to accelerate timelines: AI capabilities are delivering up to 50% cycle time reductions in IND submission generation.
2. Apply insights with agility to enable better decision-making
3. Enhance data handling to drive first-time quality through content generation and workflow automation

Biostatistical services, including SAP development, statistical programming in SAS, analysis, submission-ready services and statistical reports are customized and designed specifically to meet your project requirements.

ICON Commercialization & Outcomes (ICO) optimizes the value of drugs and medical devices through innovative strategies and tactics that reflect evolving evidentiary, regulatory, and reimbursement requirements.

Discover how a team of biostatistics and pharmacokinetics experts can offer specialized guidance for clinical trial design and analysis.